« Planning for patients: the role of Section 106 planning contributions | Main | Ethical and economic issues in the appraisal of medicines for ultra-rare conditions »

15/01/2020

Logo Kings Fund
If you prefer to receive this content via email, you can sign up to our twice-weekly bulletin here: https://www.kingsfund.org.uk/emails